Company registration number 00994783 (England and Wales)
SPRINGDENE NURSING AND CARE HOMES LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
SPRINGDENE NURSING AND CARE HOMES LIMITED
COMPANY INFORMATION
Directors
J Powell
R Powell
A Rosen
S Balcombe
M Powell
M Williams
T Powell
T Balcombe
(Appointed 1 April 2025)
Secretary
J Powell
Company number
00994783
Registered office
2 Leman Street
London
United Kingdom
E1W 9US
Auditor
Gravita Audit II Limited
Aldgate Tower
2 Leman Street
London
United Kingdom
E1 8FA
Business address
10-12 Crescent Road
Enfield
Middlesex
EN2 7BL
SPRINGDENE NURSING AND CARE HOMES LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Statement of financial position
8
Statement of changes in equity
9
Statement of cash flows
10
Notes to the financial statements
11 - 23
SPRINGDENE NURSING AND CARE HOMES LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the year ended 31 December 2024

Review of the business

During the financial year, the company has continued to focus on maintaining strong occupancy levels and further enhancing the standard of care provided to residents.

Principal risks and uncertainties

The Directors believe the business remains well positioned for continued development and growth, despite persistent challenges across the sector. These include increasing operational costs, evolving regulatory requirements, the ongoing need for comprehensive staff training, and the continued disparity between Local Authority funding and the actual cost of care. The company is actively managing these pressures through prudent financial planning and the implementation of targeted cost-efficiency measures, while remaining firmly committed to delivering high-quality care services.

Analysis based on Key Performance Indicators

December December

2024     2023

£ £

Turnover                          9,458,685 9,315,148

Operating (loss) /profit                      (100,089) 295,195

Profit/(Loss) before tax                  (45,376) 369,759

On behalf of the board

T Powell
Director
30 September 2025
SPRINGDENE NURSING AND CARE HOMES LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company was the provision of retirement and nursing homes facilities.

Results and dividends

The result for the year are set out on page 7.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

No preference dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

A Powell
(Resigned 4 June 2024)
J Powell
R Powell
A Rosen
S Balcombe
M Powell
M Williams
T Powell
T Balcombe
(Appointed 1 April 2025)
Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

SPRINGDENE NURSING AND CARE HOMES LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
T Powell
Director
30 September 2025
SPRINGDENE NURSING AND CARE HOMES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF SPRINGDENE NURSING AND CARE HOMES LIMITED
- 4 -
Opinion

We have audited the financial statements of Springdene Nursing and Care Homes Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. However, because not all future events or conditions can be predicted this statement is not a guarantee as to the company's ability to continue as a going concern.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

SPRINGDENE NURSING AND CARE HOMES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF SPRINGDENE NURSING AND CARE HOMES LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which the audit was considered capable of detecting irregularities including fraud

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

 

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

 

 

SPRINGDENE NURSING AND CARE HOMES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF SPRINGDENE NURSING AND CARE HOMES LIMITED (CONTINUED)
- 6 -

To address the risk of fraud through management bias and override of controls, we:

 

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

 

 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Mark Brown FCA (Senior Statutory Auditor)
For and on behalf of Gravita Audit II Limited, Statutory Auditor
Chartered Accountants
Aldgate Tower
2 Leman Street
London
E1 8FA
United Kingdom
30 September 2025
SPRINGDENE NURSING AND CARE HOMES LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
2024
2023
Notes
£
£
Turnover
4
9,458,685
9,315,148
Administrative expenses
(9,585,610)
(9,142,678)
Other operating income
26,836
122,725
Operating (loss)/profit
5
(100,089)
295,195
Interest receivable and similar income
9
126,689
142,987
Interest payable and similar expenses
10
(71,975)
(68,423)
Amounts written off investments
11
(1)
-
(Loss)/profit before taxation
(45,376)
369,759
Tax on (loss)/profit
12
95,532
(95,530)
Profit for the financial year
50,156
274,229

The income statement has been prepared on the basis that all operations are continuing operations.

SPRINGDENE NURSING AND CARE HOMES LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2024
31 December 2024
- 8 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
13
19,887,501
18,877,796
Investments
14
-
0
1
19,887,501
18,877,797
Current assets
Debtors
15
571,431
355,983
Cash at bank and in hand
2,669,171
3,529,018
3,240,602
3,885,001
Creditors: amounts falling due within one year
16
(2,337,065)
(1,998,052)
Net current assets
903,537
1,886,949
Total assets less current liabilities
20,791,038
20,764,746
Creditors: amounts falling due after more than one year
17
(940,118)
(963,982)
Net assets
19,850,920
19,800,764
Capital and reserves
Called up share capital
20
600,500
600,500
Revaluation reserve
21
3,720,473
3,720,473
Profit and loss reserves
22
15,529,947
15,479,791
Total equity
19,850,920
19,800,764

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 30 September 2025 and are signed on its behalf by:
T Powell
Director
Company registration number 00994783 (England and Wales)
SPRINGDENE NURSING AND CARE HOMES LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
£
£
£
£
Balance at 1 January 2023
600,500
3,734,091
15,191,944
19,526,535
Year ended 31 December 2023:
Profit and total comprehensive income
-
-
274,229
274,229
Transfers
-
(13,618)
13,618
-
Balance at 31 December 2023
600,500
3,720,473
15,479,791
19,800,764
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
50,156
50,156
Balance at 31 December 2024
600,500
3,720,473
15,529,947
19,850,920
SPRINGDENE NURSING AND CARE HOMES LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
25
647,417
410,877
Interest paid
(71,975)
(68,423)
Income taxes paid
(69,452)
(28,446)
Net cash inflow from operating activities
505,990
314,008
Investing activities
Purchase of tangible fixed assets
(1,445,375)
(1,820,795)
Proceeds on disposal of tangible fixed assets
-
0
1,099
Interest received
126,689
142,987
Net cash used in investing activities
(1,318,686)
(1,676,709)
Financing activities
Repayment of bank loans
(47,151)
(47,339)
Net cash used in financing activities
(47,151)
(47,339)
Net decrease in cash and cash equivalents
(859,847)
(1,410,040)
Cash and cash equivalents at beginning of year
3,529,018
4,939,058
Cash and cash equivalents at end of year
2,669,171
3,529,018
SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
1
Accounting policies
Company information

Springdene Nursing and Care Homes Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Leman Street, London, United Kingdom, E1W 9US. The principal place of business is 10-12 Crescent Road, Enfield, Middlesex, EN2 7BL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties at fair value. The principal accounting policies adopted are set out below.

The financial statements present information about the company as an individual undertaking and not about its group, as the subsidiary entity disposed of in the year was dormant, and hence, deemed immaterial. The company has taken the exemption under s402 of the companies act not to prepare consolidated accounts.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover comprises fees received relating to the provision of nursing and care home facilities. Nursing and care home income comprises residents fees which are recognised when delivery of the service is completed. Residents fees that are invoiced in advance are included as deferred income until the service is completed.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Buildings Freehold
50 years (Freehold land is not depreciated)
Plant and machinery
5 Year on a Straight Line basis
Fixtures, fittings & equipment
5 Year on a Straight Line basis
Computer equipment
5 Year on a Straight Line basis
Motor vehicles
5 Year on a Straight Line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

 

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 12 -
1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.6
Impairment of fixed assets

At each reporting end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 13 -
Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -
1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
2
Change in accounting policy

Change in the Depreciation method:

Effective 1 January 2024, the Company has revised its accounting policy regarding depreciation of property, plant and equipment. Previously, the Company used the reducing balance method to calculate depreciation. Since care homes frequently require regular maintenance and refurbishments that can extend their useful lives, the reducing balance method may not accurately reflect these repairs and improvements, potentially resulting in depreciation expenses that do not precisely represent the asset's true value. Going forward, the Company will adopt the straight-line method of depreciation, whereby an equal amount of depreciation expense will be recognised systematically over the estimated useful life of each asset. This change is intended to provide a more consistent reflection of the asset’s consumption pattern and enhances comparability of financial statements across periods. The impact of this change has been assessed and is reflected prospectively from 2024 , with no restatement of prior periods required. The new depreciation policy aligns with industry best practices and the Company’s strategic financial reporting objectives.

3
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
3
Judgements and key sources of estimation uncertainty
(Continued)
- 16 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Tangible assets

Accounting for tangible assets involves the use of estimates for determining the market value of freehold properties held. Land and buildings are recorded at fair value either based on directors' valuation or external valuation if there has been any significant movements in the property market.

 

At the end of each reporting period, the directors update their assessment of the fair value of each property, taking into account the most recent independent valuations. The directors determine a property's value within a range of reasonable fair value estimates.

 

The latest external valuation was performed in June 2022 by Colliers International Property Consultants, independent valuers not connected with the company on the basis of market value as a fully equipped operational entity having regard to trading potential. The valuation conforms to International Valuation Standards and was based on recent market transactions on arm's length terms for similar properties. The directors have reviewed these valuations and updated these as at 31 December 2024 as appropriate.

 

Accounting for tangible assets also involves the use of estimates for determining the useful lives over which these are to be depreciated and the existence and amount of any impairment.

 

Tangible assets are depreciated on a reducing balance or straight line basis over their estimated useful lives and taking into account their expected residual values. When the Company estimates useful lives, various factors are considered including expected technological obsolescence and the expected usage of the asset.

 

The Directors regularly review these asset lives and change them as necessary to reflect the estimated current remaining lives in light of technological changes, future economic utilisation and physical condition of the assets concerned. A significant change in asset lives can have a significant change on depreciation and amortisation charges for the period.

4
Turnover and other revenue

An analysis of the company's turnover is as follows:

2024
2023
£
£
Turnover analysed by class of business
Fees
9,381,267
9,276,955
Rent receivable
77,418
38,193
9,458,685
9,315,148
2024
2023
£
£
Other revenue
Interest income
126,689
142,987
Grants received
1,158
115,976
Other income
25,677
-
SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 17 -
5
Operating (loss)/profit
2024
2023
Operating (loss)/profit for the year is stated after charging/(crediting):
£
£
Government grants
(1,158)
(115,976)
Depreciation of owned tangible fixed assets
435,670
276,955
Operating lease charges
30,000
30,687
6
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
30,000
22,500
7
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Office and management
19
22
Administration staff and Care assistants
170
169
Total
189
191

Their aggregate remuneration comprised:

2024
2023
£
£
Wages and salaries
5,685,681
5,482,974
Social security costs
583,256
542,917
Pension costs
134,286
117,655
6,403,223
6,143,546
8
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
361,948
389,096
Company pension contributions to defined contribution schemes
15,586
18,946
377,534
408,042
SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
8
Directors' remuneration
(Continued)
- 18 -
Remuneration disclosed above include the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
90,169
73,256
9
Interest receivable and similar income
2024
2023
£
£
Interest income
Bank deposit interest
126,689
142,987
10
Interest payable and similar expenses
2024
2023
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank loans
71,975
68,423
11
Amounts written off investments
2024
2023
£
£
Loss on disposal of investments held at fair value
(1)
-
12
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
-
0
95,530
Adjustments in respect of prior periods
(95,532)
-
0
Total current tax
(95,532)
95,530
SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
12
Taxation
(Continued)
- 19 -

The actual (credit)/charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
(Loss)/profit before taxation
(45,376)
369,759
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
(11,344)
86,967
Tax effect of expenses that are not deductible in determining taxable profit
17,169
12,422
Tax effect of utilisation of tax losses not previously recognised
70,181
-
0
Unutilised tax losses carried forward
71,198
-
0
Adjustments in respect of prior years
(95,532)
-
0
Permanent capital allowances in excess of depreciation
(256,122)
(68,999)
Depreciation on assets not qualifying for tax allowances
108,918
65,140
Taxation (credit)/charge for the year
(95,532)
95,530
13
Tangible fixed assets
Buildings Freehold
Plant and machinery
Fixtures, fittings & equipment
Computer equipment
Motor vehicles
Total
£
£
£
£
£
£
Cost or valuation
At 1 January 2024
19,497,037
1,012,941
1,696,547
71,239
121,455
22,399,219
Additions
1,052,671
241,978
126,336
24,390
-
0
1,445,375
At 31 December 2024
20,549,708
1,254,919
1,822,883
95,629
121,455
23,844,594
Depreciation and impairment
At 1 January 2024
1,202,582
744,588
1,471,713
42,630
59,910
3,521,423
Depreciation charged in the year
128,105
96,069
169,173
17,744
24,579
435,670
At 31 December 2024
1,330,687
840,657
1,640,886
60,374
84,489
3,957,093
Carrying amount
At 31 December 2024
19,219,021
414,262
181,997
35,255
36,966
19,887,501
At 31 December 2023
18,294,455
268,353
224,834
28,609
61,545
18,877,796

Land and buildings were revalued in June 2022 by Colliers International Property Consultants, independent valuers not connected with the company on the basis of market value. The valuation conforms to International Valuation Standards and was based on market transactions on arm's length terms for similar properties. The directors have reviewed these valuations and updated these as at 31 December 2024 as appropriate.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
13
Tangible fixed assets
(Continued)
- 20 -

If revalued assets were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

 

2024
2023
£
£
Cost
14,932,978
13,880,309
Accumulated depreciation
(1,808,265)
(1,680,305)
Carrying value
13,124,713
12,200,004
14
Fixed asset investments
2024
2023
Notes
£
£
Investments in subsidiaries
-
0
1
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024
1
Disposals
(1)
At 31 December 2024
-
Carrying amount
At 31 December 2024
-
At 31 December 2023
1
15
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
342,442
291,990
Corporation tax recoverable
95,532
-
0
Other debtors
920
2,922
Prepayments and accrued income
132,537
61,071
571,431
355,983
SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 21 -
16
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Bank loans
18
50,650
73,937
Trade creditors
436,135
253,085
Corporation tax
-
0
69,452
Other taxation and social security
145,931
152,777
Other creditors
859,532
812,636
Accruals and deferred income
844,817
636,165
2,337,065
1,998,052
17
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Bank loans
18
940,118
963,982
18
Loans and overdrafts
2024
2023
£
£
Bank loans
990,768
1,037,919
Payable within one year
50,650
73,937
Payable after one year
940,118
963,982

The bank loan was re-financed in June-22 with the same lender, for a further 5 years. The bank loans are secured by a fixed and floating charges over the assets owned by the company. The bank loans are repayable in monthly instalments.

19
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
134,286
117,655

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
20
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
96
151
96
151
Ordinary B of £1 each
150
150
150
150
Ordinary C of £1 each
254
199
254
199
500
500
500
500
2024
2023
2024
2023
Preference share capital
Number
Number
£
£
Issued and fully paid
Redeemable of £1 each
600,000
600,000
600,000
600,000
Preference shares classified as equity
600,000
600,000
Total equity share capital
600,500
600,500

During the year, the company reclassified 55 ordinary £1 A shares into 55 C ordinary £1 shares.

21
Revaluation reserve

Revaluation reserve represents accumulated revaluations of tangible assets and deferred tax adjustments.

22
Profit and loss reserves

Retained earnings represents accumulated comprehensive income for the year and prior periods less dividends paid.

23
Related party transactions
Remuneration of key management personnel

Aggregate compensation includes salaries and pension costs.

Transactions with related parties

During the year the company entered into the following transactions with related parties:

Purchases
Purchases
2024
2023
£
£
Key management personnel
30,000
30,000

Costs above include consultancy service expenses.

SPRINGDENE NURSING AND CARE HOMES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
23
Related party transactions
(Continued)
- 23 -

The following amounts were outstanding at the reporting end date:

2024
2023
Amounts due to related parties
£
£
Key management personnel
30,792
28,951
24
Directors' transactions

At the balance sheet date the company owed the directors £553,015 (2023: £612,768).

 

No interest was accrued on the outstanding balance during the year.

 

25
Cash generated from operations
2024
2023
£
£
Profit after taxation
50,156
274,229
Adjustments for:
Taxation (credited)/charged
(95,532)
95,530
Finance costs
71,975
68,423
Investment income
(126,689)
(142,987)
Depreciation and impairment of tangible fixed assets
435,670
276,955
Other gains and losses
1
-
Movements in working capital:
Increase in debtors
(119,916)
(162,827)
Increase in creditors
431,752
1,554
Cash generated from operations
647,417
410,877
26
Analysis of changes in net funds
1 January 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
3,529,018
(859,847)
2,669,171
Borrowings excluding overdrafts
(1,037,919)
47,151
(990,768)
2,491,099
(812,696)
1,678,403
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.200A PowellR PowellA RosenS BalcombeM PowellM WilliamsT PowellT BalcombeT BalcombeJ Powell009947832024-01-012024-12-3100994783bus:CompanySecretaryDirector12024-01-012024-12-3100994783bus:Director22024-01-012024-12-3100994783bus:Director32024-01-012024-12-3100994783bus:Director42024-01-012024-12-3100994783bus:Director52024-01-012024-12-3100994783bus:Director62024-01-012024-12-3100994783bus:Director72024-01-012024-12-3100994783bus:Director82024-01-012024-12-3100994783bus:CompanySecretary12024-01-012024-12-3100994783bus:Director12024-01-012024-12-3100994783bus:Director92024-01-012024-12-3100994783bus:RegisteredOffice2024-01-012024-12-31009947832024-12-31009947832023-01-012023-12-3100994783core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3100994783core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31009947832023-12-3100994783core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3100994783core:PlantMachinery2024-12-3100994783core:FurnitureFittings2024-12-3100994783core:ComputerEquipment2024-12-3100994783core:MotorVehicles2024-12-3100994783core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3100994783core:PlantMachinery2023-12-3100994783core:FurnitureFittings2023-12-3100994783core:ComputerEquipment2023-12-3100994783core:MotorVehicles2023-12-3100994783core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3100994783core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3100994783core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3100994783core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3100994783core:CurrentFinancialInstruments2024-12-3100994783core:CurrentFinancialInstruments2023-12-3100994783core:ShareCapital2024-12-3100994783core:ShareCapital2023-12-3100994783core:RevaluationReserve2024-12-3100994783core:RevaluationReserve2023-12-3100994783core:RetainedEarningsAccumulatedLosses2024-12-3100994783core:RetainedEarningsAccumulatedLosses2023-12-3100994783core:ShareCapital2022-12-3100994783core:RevaluationReserve2022-12-3100994783core:RetainedEarningsAccumulatedLosses2022-12-3100994783core:ShareCapitalOrdinaryShareClass22024-12-3100994783core:ShareCapitalOrdinaryShareClass22023-12-3100994783core:ShareCapitalOrdinaryShareClass32024-12-3100994783core:ShareCapitalOrdinaryShareClass32023-12-3100994783core:ShareCapitalOrdinaryShareClass42024-12-3100994783core:ShareCapitalOrdinaryShareClass42023-12-3100994783core:ShareCapitalOrdinaryShares2024-12-3100994783core:ShareCapitalOrdinaryShares2023-12-3100994783core:RevaluationReserve2023-01-012023-12-310099478312024-01-012024-12-310099478312023-01-012023-12-31009947832023-12-31009947832022-12-3100994783core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3100994783core:PlantMachinery2024-01-012024-12-3100994783core:FurnitureFittings2024-01-012024-12-3100994783core:ComputerEquipment2024-01-012024-12-3100994783core:MotorVehicles2024-01-012024-12-3100994783core:UKTax2024-01-012024-12-3100994783core:UKTax2023-01-012023-12-3100994783core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3100994783core:PlantMachinery2023-12-3100994783core:FurnitureFittings2023-12-3100994783core:ComputerEquipment2023-12-3100994783core:MotorVehicles2023-12-3100994783core:Non-currentFinancialInstruments2024-12-3100994783core:Non-currentFinancialInstruments2023-12-3100994783bus:OrdinaryShareClass22024-01-012024-12-3100994783bus:OrdinaryShareClass32024-01-012024-12-3100994783bus:OrdinaryShareClass42024-01-012024-12-3100994783bus:PreferenceShareClass12024-01-012024-12-3100994783bus:OrdinaryShareClass22024-12-3100994783bus:OrdinaryShareClass22023-12-3100994783bus:OrdinaryShareClass32024-12-3100994783bus:OrdinaryShareClass32023-12-3100994783bus:OrdinaryShareClass42024-12-3100994783bus:OrdinaryShareClass42023-12-3100994783bus:AllOrdinaryShares2024-12-3100994783bus:AllOrdinaryShares2023-12-3100994783bus:PrivateLimitedCompanyLtd2024-01-012024-12-3100994783bus:FRS1022024-01-012024-12-3100994783bus:Audited2024-01-012024-12-3100994783bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP